In 20 patients with various clinical variants of neurotic depression, regional organization of the brain bioelectric activity was studied with the aid of cross-correlation, factorial and coherent analyses. Clinical picture of neurotic depression was reflected within the frame of regional organization of the EEG. Regional organization EEG is modified depending on the degree of neurotic depression manifestation and concomitant syndromes of alarm and asthenia. In depressive syndrome without concomitant asthenic and disturbing, the maximum changes are registered in the right fronto-temporal range--left post-temporal areas. In depression and the alarm, depression cross-correlation and coherent communications in fronto-temporal areas of both hemispheres were recorded. In depressive and disturbing syndromes with the asthenic manifestations, depression cross-correlation and coherent communications in fronto-temporal areas of both hemispheres were observed.
Download full-text PDF |
Source |
|---|
Publication Analysis
Top Keywords
Similar Publications
Vegetable Intake and Major Depressive Disorder: Insights and Future Directions for Nutritional Psychiatry.
Public Health Nutr
January 2025
Department of Theology and Religious Education, De La Salle University, 2401 Taft Avenue, 1004 Manila, Philippines,
Effect of psilocybin versus escitalopram on depression symptom severity in patients with moderate-to-severe major depressive disorder: observational 6-month follow-up of a phase 2, double-blind, randomised, controlled trial.
EClinicalMedicine
October 2024
Centre for Psychedelic Research, Division of Psychiatry, Department Brain Sciences, Imperial College London, United Kingdom.
Background: Psilocybin therapy (PT) produces rapid and persistent antidepressant effects in major depressive disorder (MDD). However, the long-term effects of PT have never been compared with gold-standard treatments for MDD such as pharmacotherapy or psychotherapy alone or in combination.
Methods: This is a 6-month follow-up study of a phase 2, double-blind, randomised, controlled trial involving patients with moderate-to-severe MDD.
Electroconvulsive Therapy-Induced Mania in Bipolar Disorder: A Case Report.
Cureus
December 2024
Psychiatry, Psychiatrisch Ziekenhuis Asster, Sint-Truiden, BEL.
Electroconvulsive therapy (ECT) is widely recognized as a safe and effective intervention for treating severe affective episodes in patients with bipolar disorder. However, it can sometimes precipitate unexpected manic phases in patients treated for a depressive episode, a phenomenon known as ECT-induced mania. While this occurrence is recognized, it remains poorly understood and minimally addressed in the literature.
View Article and Find Full Text PDFThe role of brain-derived neurotrophic factor and its recombinant pro-isoforms in depressive disorder: Open questions.
Biotechnol Notes
September 2024
Biotechnology Unit, University of Ribeirão Preto/UNAERP, Ribeirão Preto, SP, Brazil.
The current state of mental health treatment for individuals diagnosed with major depressive disorder leaves billions of individuals with first-line therapies that are ineffective or burdened with undesirable side effects. One major obstacle is that distinct pathologies may currently be diagnosed as the same disease and prescribed the same treatments. The key to developing antidepressants with ubiquitous efficacy is to first identify a strategy to differentiate between heterogeneous conditions.
View Article and Find Full Text PDFWant AI Summaries of new PubMed Abstracts delivered to your In-box?
Enter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!